Electrocatalytic Reduction of Disulfide Bonds in Antibodies

Serge Ruccolo,Marion, H. Emmert,Cecilia Bottecchia,Yangzhong Qin,Rodell Barrientos,Kelly Raymond,Monica Haley
DOI: https://doi.org/10.26434/chemrxiv-2024-24nj1
2024-02-19
Abstract:In most FDA-approved antibody-drug conjugates, cysteines generated through reduction of the native interchain di-sulfide bonds in monoclonal antibodies (mAbs) are conjugated with maleimide-based cytotoxic payloads. Despite being key to efficiently producing well-defined conjugates, selective disulfide reduction strategies are severely underdevel-oped. Herein, we report a vitamin B12-catalyzed, electrochemically driven protocol that efficiently reduces disulfide bonds in various aqueous buffers and at a broad pH range. This robust and simple method is suitable for disulfide reduc-tions of substrates ranging from biologically relevant small molecules to large proteins. Finally, one-pot reduc-tion/conjugation of disulfide bonds in mAbs was achieved to access antibody conjugates.
Chemistry
What problem does this paper attempt to address?